Actual Medicinal Product (AMP) Voriconazole 50mg tablets (Alliance Healthcare (Distribution) Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from VFEND 50mg tablets (Pfizer Ltd).

Generic
Voriconazole
Formulation
Voriconazole 50mg tablets
  • Voriconazole
    • Voriconazole 50mg tablets

      • Voriconazole 50mg tablets (Alliance Healthcare (Distribution) Ltd)